COSCIENS Biopharma Inc T.AEZS

Healthcare Biotechnology

COSCIENS Biopharma Inc., formerly Aeterna Zentaris Inc., is a specialty biopharmaceutical company engaged in the development and commercialization of a diverse portfolio of pharmaceutical and diagnostic products, including those focused on areas of unmet medical need. Its lead product, macimorelin (Macrilen; Ghryvelin), is an oral test indicated for the diagnosis of adult growth hormone deficiency (AGHD). The Company is also engaged in the development of therapeutic assets and proprietary extraction technology, which is applied to the production of active ingredients from renewable plant resources used in cosmeceutical products (i.e., oat beta glucan and avenanthramides, which are found in skincare product brands like Aveeno and Burt’s Bees formulations) and being developed as potential nutraceuticals and/or pharmaceuticals.

TSX:AEZS - Post by User

COSCIENS Biopharma Inc > True to form

<< Previous

Bullboard Posts

Next >>

Comment by prophetoffactzon Jun 04, 2024 4:36pm

72 Views

Post# 36071951

RE:True to form

If you don't even know that AEZS is down because AEZS no longer has the warrants attached and thus the stock has declined the value of the warrants you really shouldn't be posting. How embarrassing.

Hopeforthebest wrote: Well, at least the gagnon is predictable. Since the devaulation of Czo stocks, their value have dropped by almost 17%, in 2 trading days. true to form, gagnon controlled company will only result in shareholders loosing their money while gagnon and his pals rake in millions.

<< Previous

Bullboard Posts

Next >>

Apolo IV Acquisition and Marviken Ontario sign merger agreement